Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1777–1781. doi: 10.1128/aac.35.9.1777

Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.

A Iravani 1
PMCID: PMC245267  PMID: 1952847

Abstract

In a double-blind, randomized, multicenter study, 400 women with symptoms of acute urinary tract infections were treated with either a 7-day course of temafloxacin hydrochloride (400 mg once a day; n = 204) or a 10-day course of trimethoprim (160 mg) and sulfamethoxazole (800 mg) (TMP-SMZ) twice daily (n = 196). The bacteriologic cure rates at 5 to 9 days posttherapy were 100% in the temafloxacin group and 97% in the TMP-SMZ group (P = 0.035). The clinical cure rates were 93% in the temafloxacin group and 95% in the TMP-SMZ group (P greater than 0.1). Adverse events, including nausea, vomiting, rash, headache, and dizziness, were experienced by 19.6% of the temafloxacin group and 23.5% of the TMP-SMZ group. Transient leukopenia occurred in 0.5 and 4.1% of the temafloxacin and TMP-SMZ groups, respectively. Temafloxacin, 400 mg once a day for 7 days, appears to be at least as safe and effective as a 10-day course of TMP-SMZ in the management of acute urinary tract infection in women.

Full text

PDF
1777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allais J. M., Preheim L. C., Cuevas T. A., Roccaforte J. S., Mellencamp M. A., Bittner M. J. Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections. Antimicrob Agents Chemother. 1988 Sep;32(9):1327–1330. doi: 10.1128/aac.32.9.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Boyko E. J., Iravani A., Silverman M. H., Schelling D. J., Wright R. A. Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group. Antimicrob Agents Chemother. 1990 Apr;34(4):665–667. doi: 10.1128/aac.34.4.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brumfitt W., Pursell R. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. Br Med J. 1972 Jun 17;2(5815):673–676. doi: 10.1136/bmj.2.5815.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Childs S. J. Management of urinary tract infections. Am J Med. 1988 Sep 16;85(3A):14–16. doi: 10.1016/0002-9343(88)90458-5. [DOI] [PubMed] [Google Scholar]
  6. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fennell R. S., Luengnaruemitchai M., Iravani A., Garin E. H., Walker R. D., Richard G. A. Urinary tract infections in children: effect of short course antibiotic therapy on recurrence rate in children with previous infections. Clin Pediatr (Phila) 1980 Feb;19(2):121–124. doi: 10.1177/000992288001900206. [DOI] [PubMed] [Google Scholar]
  8. Hooton T. M., Latham R. H., Wong E. S., Johnson C., Roberts P. L., Stamm W. E. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother. 1989 Aug;33(8):1308–1312. doi: 10.1128/aac.33.8.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iravani A., Richard G. A. Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother. 1986 Jan;29(1):107–111. doi: 10.1128/aac.29.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iravani A., Richard G. A., Baer H. Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora. Antimicrob Agents Chemother. 1981 May;19(5):842–850. doi: 10.1128/aac.19.5.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iravani A., Richard G. A., Baer H. Trimethoprim once daily vs. nitrofurantoin in treatment of acute urinary tract infections in young women, with special reference to periurethral, vaginal, and fecal flora. Rev Infect Dis. 1982 Mar-Apr;4(2):378–387. doi: 10.1093/clinids/4.2.378. [DOI] [PubMed] [Google Scholar]
  12. Iravani A., Richard G. A., Johnson D., Bryant A. A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. Am J Med. 1988 Sep 16;85(3A):17–23. doi: 10.1016/0002-9343(88)90459-7. [DOI] [PubMed] [Google Scholar]
  13. Iravani A., Richard G. A. Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections. Antimicrob Agents Chemother. 1985 Feb;27(2):158–161. doi: 10.1128/aac.27.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iravani A., Richard G. A. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. Antimicrob Agents Chemother. 1989 Aug;33(8):1212–1216. doi: 10.1128/aac.33.8.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stamm W. E., McKevitt M., Counts G. W. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial. Ann Intern Med. 1987 Mar;106(3):341–345. doi: 10.7326/0003-4819-106-3-341. [DOI] [PubMed] [Google Scholar]
  16. Then R. L. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):261–269. doi: 10.1093/clinids/4.2.261. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES